387
edits
Changes
Created page with '{{Drugcombi | base = topiramate | add = risperidone | info = * Topiramate induces CYP3A4 and is an inhibitor of CYP2C19. * Risperidone is principally metabolized by CYP2D6 to an...'
{{Drugcombi
| base = topiramate
| add = risperidone
| info =
* Topiramate induces CYP3A4 and is an inhibitor of CYP2C19.
* Risperidone is principally metabolized by CYP2D6 to an active metabolite.
* This combination of drugs may have possible synergistic effects. However, this combination will also have additive side effects. Dose adaptation will be recommended for this combination.
| start =
* Start risperidone according general dosing advice.
| cave =
* Caution is advised when topiramate is prescribed with other drugs that predispose patients to heat-related disorders, including carbonic anhydrase inhibitors and drugs with anticholinergic activity. <ref name="drugscom">{{DRUGSCOM|risperidone}}</ref>
}}
| base = topiramate
| add = risperidone
| info =
* Topiramate induces CYP3A4 and is an inhibitor of CYP2C19.
* Risperidone is principally metabolized by CYP2D6 to an active metabolite.
* This combination of drugs may have possible synergistic effects. However, this combination will also have additive side effects. Dose adaptation will be recommended for this combination.
| start =
* Start risperidone according general dosing advice.
| cave =
* Caution is advised when topiramate is prescribed with other drugs that predispose patients to heat-related disorders, including carbonic anhydrase inhibitors and drugs with anticholinergic activity. <ref name="drugscom">{{DRUGSCOM|risperidone}}</ref>
}}